These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetic features of precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement. Yoshida M; Tomizawa D; Yoshimura S; Osumi T; Nakabayashi K; Ogata-Kawata H; Ishiwata K; Sato-Otsubo A; Kimura Y; Ito S; Matsumoto K; Deguchi T; Kiyokawa N; Yoshioka T; Hata K; Kato M Cancer Rep (Hoboken); 2022 Jul; 5(7):e1545. PubMed ID: 34472720 [TBL] [Abstract][Full Text] [Related]
3. Molecular characteristics of terminal deoxynucleotidyl transferase negative precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement. Yoon J; Yun JW; Jung CW; Ju HY; Koo HH; Kim SH; Kim HJ Genes Chromosomes Cancer; 2020 Apr; 59(4):255-260. PubMed ID: 31705772 [TBL] [Abstract][Full Text] [Related]
4. B Lymphoblastic Leukemia/Lymphoma With Burkitt-like Morphology and IGH/MYC Rearrangement: Report of 3 Cases in Adult Patients. Li Y; Gupta G; Molofsky A; Xie Y; Shihabi N; McCormick J; Jaffe ES Am J Surg Pathol; 2018 Feb; 42(2):269-276. PubMed ID: 29112016 [TBL] [Abstract][Full Text] [Related]
5. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma. Wagener R; Seufert J; Raimondi F; Bens S; Kleinheinz K; Nagel I; Altmüller J; Thiele H; Hübschmann D; Kohler CW; Nürnberg P; Au-Yeung R; Burkhardt B; Horn H; Leoncini L; Jaffe ES; Ott G; Rymkiewicz G; Schlesner M; Russell RB; Klapper W; Siebert R Blood; 2019 Feb; 133(9):962-966. PubMed ID: 30567752 [TBL] [Abstract][Full Text] [Related]
6. Erroneous class switching and false VDJ recombination: molecular dissection of t(8;14)/MYC-IGH translocations in Burkitt-type lymphoblastic leukemia/B-cell lymphoma. Burmeister T; Molkentin M; Schwartz S; Gökbuget N; Hoelzer D; Thiel E; Reinhardt R Mol Oncol; 2013 Aug; 7(4):850-8. PubMed ID: 23673335 [TBL] [Abstract][Full Text] [Related]
7. Burkitt lymphoma/leukaemia transformed from a precursor B cell: clinical and molecular aspects. Hassan R; Felisbino F; Stefanoff CG; Pires V; Klumb CE; Dobbin J; Seuánez HN; Renault IZ Eur J Haematol; 2008 Mar; 80(3):265-70. PubMed ID: 18005389 [TBL] [Abstract][Full Text] [Related]
8. Burkitt Leukemia With Precursor B-Cell Immunophenotype and Dual Translocation of t(14;18) and t(8;14) in a Child: Case Report and Review of the Literature. Odaman Al I; Bayram C; Koç B; Ersoy G; Pasli Uysalol E; Aki H; Özdemir GN J Pediatr Hematol Oncol; 2020 Jan; 42(1):e61-e63. PubMed ID: 30499905 [TBL] [Abstract][Full Text] [Related]
9. Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior. McClure RF; Remstein ED; Macon WR; Dewald GW; Habermann TM; Hoering A; Kurtin PJ Am J Surg Pathol; 2005 Dec; 29(12):1652-60. PubMed ID: 16327438 [TBL] [Abstract][Full Text] [Related]
10. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge. Boerma EG; Siebert R; Kluin PM; Baudis M Leukemia; 2009 Feb; 23(2):225-34. PubMed ID: 18923440 [TBL] [Abstract][Full Text] [Related]
11. High-grade B-cell lymphoma with concurrent MYC rearrangement and 11q aberrations: clinicopathologic, cytogenetic, and molecular characterization of 4 cases. Shestakova A; Shao L; Smith LB; Ryan R; Bedell V; Murata-Collins J; Zhang W; Perry AM; Song JY Hum Pathol; 2023 Jun; 136():34-43. PubMed ID: 36997031 [TBL] [Abstract][Full Text] [Related]
13. Low incidence of MYC/BCL2 double-hit in Burkitt lymphoma. Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Niino D; Ohshima K Pathol Int; 2015 Sep; 65(9):486-9. PubMed ID: 26182827 [TBL] [Abstract][Full Text] [Related]
14. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma. López C; Kleinheinz K; Aukema SM; Rohde M; Bernhart SH; Hübschmann D; Wagener R; Toprak UH; Raimondi F; Kreuz M; Waszak SM; Huang Z; Sieverling L; Paramasivam N; Seufert J; Sungalee S; Russell RB; Bausinger J; Kretzmer H; Ammerpohl O; Bergmann AK; Binder H; Borkhardt A; Brors B; Claviez A; Doose G; Feuerbach L; Haake A; Hansmann ML; Hoell J; Hummel M; Korbel JO; Lawerenz C; Lenze D; Radlwimmer B; Richter J; Rosenstiel P; Rosenwald A; Schilhabel MB; Stein H; Stilgenbauer S; Stadler PF; Szczepanowski M; Weniger MA; Zapatka M; Eils R; Lichter P; Loeffler M; Möller P; Trümper L; Klapper W; ; Hoffmann S; Küppers R; Burkhardt B; Schlesner M; Siebert R Nat Commun; 2019 Mar; 10(1):1459. PubMed ID: 30926794 [TBL] [Abstract][Full Text] [Related]
15. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations? Mationg-Kalaw E; Tan LH; Tay K; Lim ST; Tang T; Lee YY; Tan SY Histopathology; 2012 Dec; 61(6):1214-8. PubMed ID: 23171357 [TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement. Kelemen K; Holden J; Johnson LJ; Davion S; Robetorye RS Cytometry B Clin Cytom; 2017 Jul; 92(4):310-314. PubMed ID: 26517296 [TBL] [Abstract][Full Text] [Related]
17. Application of 2016 WHO classification in the diagnosis of paediatric high-grade Zhang L; Brown LE; Bowen LM; McCarthy LC; Cooley LD; Repnikova E; Gener MA; Garola R; August KJ; Hays JA; Zwick DL; Li W J Clin Pathol; 2020 Sep; 73(9):563-570. PubMed ID: 31964683 [TBL] [Abstract][Full Text] [Related]
18. Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement. Havelange V; Ameye G; Théate I; Callet-Bauchu E; Mugneret F; Michaux L; Dastugue N; Penther D; Barin C; Collonge-Rame MA; Baranger L; Terré C; Nadal N; Lippert E; Laï JL; Cabrol C; Tigaud I; Herens C; Hagemeijer A; Raphael M; Libouton JM; Poirel HA; Genes Chromosomes Cancer; 2013 Jan; 52(1):81-92. PubMed ID: 23012230 [TBL] [Abstract][Full Text] [Related]
19. Submicroscopic genomic imbalances in Burkitt lymphomas/leukemias: association with age and further evidence that 8q24/MYC translocations are not sufficient for leukemogenesis. Lundin C; Hjorth L; Behrendtz M; Ehinger M; Biloglav A; Johansson B Genes Chromosomes Cancer; 2013 Apr; 52(4):370-7. PubMed ID: 23225516 [TBL] [Abstract][Full Text] [Related]
20. Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma. Onnis A; De Falco G; Antonicelli G; Onorati M; Bellan C; Sherman O; Sayed S; Leoncini L PLoS One; 2010 Sep; 5(9):. PubMed ID: 20930934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]